PRKN and cancer: Therefore, our findings strengthen our knowledge on the regulatory mechanism of PKM2 enzymatic activity by Parkin‐mediated polyubiquitination and the biological function of VAL in various cancer‐related contexts, which further provide a foundation for targeting VAL or PKM2 as potential biomarkers in GC diagnosis and treatment.